- €26.24m
- €18.95m
- €4.47m
Brief: NanoRepro closes cooperation agreement with AristoPharma Iberia SL
Brief: NanoRepro's products approved for trading in drugstore and retail chains in Germany
Brief: NanoRepro H1 sales down at EUR 177,000
Brief: Nanorepro enters into two new distribution partnerships in E-Commerce
Brief: Nanorepro signs distribution agreement for Romania and Moldova
Brief: Nanorepro enters into strategic partnership with Gruenspecht Naturprodukte GmbH
Brief: Nanorepro FY 2014 net loss narrows to EUR 27,000
Brief: NanoRepro receives about 1.5 mln euros from capital increase
Brief: NanoRepro informs about subscription period for capital increase
Brief: NanoRepro buys brand alphabiol from Alphablom AG
Brief: NanoRepro plans capital increase with subscription rights
Brief: NanoRepro plans capital increase with subscription rights
Brief: NanoRepro announces European approval of HIV-QUICK
Brief: NanoRepro concludes framework agreement for 1.85 mln euros
Brief: NanoRepro says is near approval of its HIV test